Rongshan Li, Ph.D.

Rongshan Li, PhD

Instructor

Department of Pharmacy

Tianjin Medical  University

22 Qixiangtai Road

Tianjin 3000070

Phone: +86-22-83336658

Email: lirongshan@tmu.edu.cn

Education

B.S.      China Pharmaceutical University, Nanjing, China, 2003

M.S.     China Pharmaceutical University, Nanjing, China, 2006

Ph.D.   Tianjin Medical University, Tianjin, China, 2011

Professional Experience

2006-     Instructor, Department of Pharmacy, Tianjin Medical University, Tianjin, China

Publication

1、  Tao Zhang^#, Hui Liu^#, Ling Li,  Zhaoyang Guo, Jia Song, Xiaoying Yang , Guoyun Wan , Rongshan Li*, Yinsong Wang*, Leukocyte/platelet hybrid membrane-camouflaged dendritic large pore mesoporous silica nanoparticles co-loaded with photo/chemotherapeutic agents for triple negative breast cancer combination treatment, Bioactive Materials, 2021, 6(11): 3865-3878.

2、  Ruixue Ran^#, Chunze Zhang^#, Rongshan Li, Bowei Chen, Weihua Zhang, Zhenying Zhao, Zhiwei Fu, Zuo Du, Xiaolang Du, Xiaolong Yang, Zhongze Fang*, Evaluation and Comparison of the Inhibition Effect of Astragaloside IV and Aglycone Cycloastragenol on Various UDP-Glucuronosyltransferase (UGT) Isoforms, Molecules, 2016, 21(12). pii: E1616.

3、  Rongshan Li*, Ruixue Ran, Quansheng Li, Yurong Huang, Yuan Gu, Duanyun Si, Development of an LC-MS/MS method for the quantitation of deoxyglycychloxazol in rat plasma and its application in pharmacokinetic study, Journal of Pharmaceutical Analysis, 2016, 6: 184-189.

4、  Li Rongshan, Fan Huirong, Lu Rong, Gu Yuan, Si Duanyun, Liu Changxiao*.  Determination of scicinib, a promising thiosemicarbazone anticancer candidate in rat plasma by LC-MS/MS and its application to a preclinical pharmacokinetics study.Journal of Liquid Chromatography & Related Technologies, 2013, 36(3): 372-383.

5、  Yinsong Wang*, Chen Hongli, Liu Yuanyuan, Wu Jing, Zhou Ping, Wang Yan, Li Rongshan, Yang Xiaoying, Zhang Ning*. pH-sensitive pullulan-based nanoparticle carrier of methotrexate and combretastatin A4 for the combination therapy against hepatocellular carcinoma. Biomaterial, 2013, 34(29): 7181-7190.

Grant

Completed:

1、The construction and study of a liver-targeted nanoparticle co-carrier of piperine and chemotherapeutic drug， the Natural Science Foundation of Tianjin (Grant No. 15JCQNJC46100)， 2015.3-2018.3.